Treatment of acute hepatitis C virus infection in HIV-infected MSM: the effect of treatment duration
- 19 June 2011
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in AIDS
- Vol. 25 (10), 1333-1336
- https://doi.org/10.1097/qad.0b013e3283480144
Abstract
We evaluated hepatitis C virus (HCV) treatment and the effect of treatment duration (24 versus 48 weeks) on treatment outcome among 50 HIV-infected men who have sex with men with acute HCV infection in Amsterdam. Overall sustained virological response (SVR) rate was 76%. Treatment duration was not significantly associated with SVR (adjusted odds ratio = 2.32; 95% confidence interval 0.39-13.97), suggesting that 24-week treatment may be sufficient for acute HCV infection in HIV-coinfected patientKeywords
This publication has 15 references indexed in Scilit:
- Acute hepatitis C in HIV-infected individuals: recommendations from the European AIDS Treatment Network (NEAT) consensus conferenceAIDS, 2011
- Treatment of acute hepatitis C in human immunodeficiency virus-infected patients: The HEPAIG studyHepatology, 2010
- Acute hepatitis C in HIV-infected men who have sex with men: an emerging sexually transmitted infectionAIDS, 2010
- Potential role for Interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infectionHepatology, 2010
- Treatment of Acute HCV Infection in HIV-Positive Patients: Experience from a Multicentre European CohortAntiviral Therapy, 2010
- Treatment of acute hepatitis C in HIV infectionJournal of Antimicrobial Chemotherapy, 2009
- Characteristics and Treatment Outcomes among HIV‐Infected Individuals in the Australian Trial in Acute Hepatitis CClinical Infectious Diseases, 2009
- Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCVAIDS, 2009
- Diagnosis, management, and treatment of hepatitis C: An updateHepatology, 2008
- Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV–HIV International PanelAIDS, 2007